Table 1 Antiviral effect of silver nanoparticles against HIV-1 strains
From: Mode of antiviral action of silver nanoparticles against HIV-1
HIV-1 strain | Tropism (co-receptor) | IC50 (mg/mL)* | HeLa cells CC50 (mg/mL)* | TI |
|---|---|---|---|---|
IIIB | T (X4) | 0.44 (± 0.3) | 3.9 (± 1.6) | 8.9 |
Eli | T (X4) | 0.42 (± 0.2) |  | 9.3 |
Beni | T (X4) | 0.19 (± 0.1) |  | 20.5 |
96USSN20 | T (X4)/M (R5) | 0.36 (± 0.2) |  | 12.5 |
Bal | M (R5) | 0.27 (± 0.2) |  | 14.4 |
BCF01 | M (R5) | 0.37 (± 0.3) |  | 10.5 |
AZTRV | T (X4) | 0.19 (± 0.01) |  | 20.5 |
NNRTIRV | T (X4) | 0.61 (± 0.24) |  | 6.4 |
PIRV | T (X4) | 0.91 (± 0.09) |  | 4.3 |
3TCRV | T (X4) | 0.73 (± 0.12) |  | 5.3 |
SaquinavirRV | T (X4) | 0.81 (± 0.11) |  | 4.8 |